Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 2/20 | 0.84 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.84 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.84 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.84 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.84 |
| ▸ | MAOB | P27338 | 6/20 | 0.76 |
| ▸ | MAOA | P21397 | 5/20 | 0.76 |
| ▸ | GFER | P55789 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenethylamine SCHEMBL1331271 | 0.92 | — | — | |
| Phenethylamine SCHEMBL1330939 | 0.92 | — | — | |
| Phenethylamine SCHEMBL1332244 | 0.92 | — | — | |
| Phenethylamine SCHEMBL1799333 | 0.92 | HTR2A (1.00) | HTR2ACYP2A6SMN1; SMN2TAAR1LOXL2 | |
| Phenethylamine SCHEMBL968 | 0.92 | — | — | |
| Phenethylamine SCHEMBL8384113 | 0.89 | HTR2A (0.94) | HTR2ACYP2A6SMN1; SMN2TAAR1LOXL2 | |
| Phenethylamine SCHEMBL245154 | 0.89 | HTR2A (0.94) | HTR2ACYP2A6SMN1; SMN2TAAR1LOXL2 | |
| Phenethylamine SCHEMBL20568335 | 0.89 | HTR2A (0.94) | HTR2ACYP2A6SMN1; SMN2TAAR1LOXL2 | |
| Phenethylamine SCHEMBL10592571 | 0.89 | HTR2A (0.94) | HTR2ACYP2A6SMN1; SMN2TAAR1LOXL2 | |
| Phenethylamine SCHEMBL837569 | 0.89 | HTR2A (0.94) | HTR2ACYP2A6SMN1; SMN2TAAR1LOXL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10287235-B2 | Isomerization method for 1,3,3-trimethyl-1-(aminomethyl)aminocyclohexane | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2019-05-14 | — | — | US | disclosed |
| US-20180037537-A1 | ISOMERIZATION METHOD FOR 1,3,3-TRIMETHYL-1-(AMINOMETHYL)AMINOCYCLOHEXANE | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2018-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180037537-A1 | ISOMERIZATION METHOD FOR 1,3,3-TRIMETHYL-1-(AMINOMETHYL)AMINOCYCLOHEXANE | AP1M1, PRMT1, AP3M1 | HTR2A 2401/4885CYP2A6 1691/4885SMN1; SMN2 2661/4885 |
| US-10287235-B2 | Isomerization method for 1,3,3-trimethyl-1-(aminomethyl)aminocyclohexane | AP1M1, PRMT1, AP3M1 | HTR2A 2401/4885CYP2A6 1691/4885SMN1; SMN2 2661/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.